Ok @Huoya
Mas o investimento também impactou os resultados não ?
No Anual Report encontrei a seguinte informação que bate com os quadros da Bastter:
Investing activities use of $14.9 billion was for acquisitions, net of cash acquired of $35.2 billion (primarily the acquisitions of Actelion and AMO for approximately $29.6 billion and $4.3 billion, respectively) and additions to property, plant and equipment of $3.3 billion. This was partially offset by proceeds from the net sale of investments primarily marketable securities of $22.0 billion and $1.8 billion of proceeds from the disposal of assets/businesses (primarily the divestitures of Codman Neurosurgery and COMPEED®).
No mesmo documento aparece a informação abaixo, mas não tal este documento:
See Note 20 to the Consolidated Financial Statements for additional details regarding the acquisition.
#5 de 7
